S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
Log in

Cryoport Stock Forecast, Price & News

-1.48 (-2.42 %)
(As of 02/25/2021 12:00 AM ET)
Today's Range
Now: $59.60
50-Day Range
MA: $67.10
52-Week Range
Now: $59.60
Volume684,034 shs
Average Volume751,987 shs
Market Capitalization$2.36 billion
P/E RatioN/A
Dividend YieldN/A
Cryoport, Inc. provides temperature-controlled logistics and biostorage services to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Global Logistics Solutions and Global Bioservices. The Global Logistics Solutions segment offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. This segment also provides Cryoport Express Advanced Therapy Shippers, which offer verification information and supply chain support for biopharma companies; and Cryoport Express C3 Shippers, a non-cryogenic temperature-controlled shipper designed to maintain a controlled temperature. In addition, it offers Cryoport Express SmartPak II Condition Monitoring System to track the key aspects and condition of each shipment; and Cryoport Express Analytics to track the time-based metrics for order processing time and on-time deliveries, as well as profiling shipping lanes to determine average transit times and predicting shipping exceptions based on historical metric. The Global Bioservices segment provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens. The company also offers logistics support and management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
Cryoport logo


First Week of CYRX April 16th Options Trading
February 23, 2021 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:CYRX
Year FoundedN/A



Sales & Book Value

Annual Sales$33.94 million
Book Value$3.52 per share


Net Income$-18,330,000.00


Market Cap$2.36 billion
Next Earnings Date3/4/2021 (Estimated)


Overall MarketRank

1.28 out of 5 stars

Transportation Sector

91st out of 238 stocks

Pharmaceutical Preparations Industry

365th out of 771 stocks

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
-1.48 (-2.42 %)
(As of 02/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cryoport (NASDAQ:CYRX) Frequently Asked Questions

Is Cryoport a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cryoport stock.
View analyst ratings for Cryoport
or view top-rated stocks.

What stocks does MarketBeat like better than Cryoport?

Wall Street analysts have given Cryoport a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cryoport wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cryoport?

Cryoport saw a decline in short interest during the month of January. As of January 29th, there was short interest totaling 3,310,000 shares, a decline of 54.0% from the January 14th total of 7,200,000 shares. Based on an average daily volume of 821,400 shares, the days-to-cover ratio is currently 4.0 days.
View Cryoport's Short Interest

When is Cryoport's next earnings date?

Cryoport is scheduled to release its next quarterly earnings announcement on Thursday, March 4th 2021.
View our earnings forecast for Cryoport

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) released its quarterly earnings data on Thursday, November, 5th. The consumer goods maker reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $0.16. The consumer goods maker had revenue of $11.20 million for the quarter, compared to the consensus estimate of $10.55 million. Cryoport had a negative net margin of 55.87% and a negative trailing twelve-month return on equity of 17.68%. The firm's quarterly revenue was up 16.7% on a year-over-year basis. During the same period last year, the company earned ($0.05) earnings per share.
View Cryoport's earnings history

How has Cryoport's stock been impacted by COVID-19 (Coronavirus)?

Cryoport's stock was trading at $16.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CYRX stock has increased by 258.6% and is now trading at $59.60.
View which stocks have been most impacted by COVID-19

What price target have analysts set for CYRX?

7 analysts have issued 12 month target prices for Cryoport's stock. Their forecasts range from $25.00 to $81.00. On average, they expect Cryoport's stock price to reach $52.43 in the next twelve months. This suggests that the stock has a possible downside of 12.0%.
View analysts' price targets for Cryoport
or view top-rated stocks among Wall Street analysts.

Who are Cryoport's key executives?

Cryoport's management team includes the following people:
  • Mr. Jerrell W. Shelton, Chairman, Pres & CEO (Age 76, Pay $945k)
  • Mr. Robert S. Stefanovich, CFO, Treasurer & Corp. Sec. (Age 56, Pay $431.88k)
  • Tony Ippolito, VP & Gen. Counsel
  • Mr. Thomas J. Heinzen, VP of Corp. Devel.
  • Mr. Bret Bollinger, Chief Technology Officer of Cryoport Systems (Age 54)
  • Mr. Phil Wilson, Chief Operating Officer of Cryoport Systems
  • Dr. Mark W. Sawicki Ph.D., Pres & CEO of Cryoport Systems
  • Mr. Raymond Takahashi M.D., Exec. Officer
  • Mr. David Petreccia M.D., Exec. Officer

Who are some of Cryoport's key competitors?

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Square (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.33%), Clearbridge Investments LLC (2.47%), Janus Henderson Group PLC (2.43%), Victory Capital Management Inc. (2.17%), Federated Hermes Inc. (1.74%) and Handelsbanken Fonder AB (1.69%). Company insiders that own Cryoport stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich.
View institutional ownership trends for Cryoport

Which institutional investors are selling Cryoport stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Select Equity Group L.P., Federated Hermes Inc., JPMorgan Chase & Co., GW&K Investment Management LLC, Voloridge Investment Management LLC, Janus Henderson Group PLC, Next Century Growth Investors LLC, and Creative Planning.
View insider buying and selling activity for Cryoport
or view top insider-selling stocks.

Which institutional investors are buying Cryoport stock?

CYRX stock was purchased by a variety of institutional investors in the last quarter, including Bamco Inc. NY, Victory Capital Management Inc., Redwood Investments LLC, BlackRock Inc., Clearbridge Investments LLC, Lord Abbett & CO. LLC, WCM Investment Management LLC, and WCM Investment Management LLC.
View insider buying and selling activity for Cryoport
or or view top insider-buying stocks.

How do I buy shares of Cryoport?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $59.60.

How much money does Cryoport make?

Cryoport has a market capitalization of $2.36 billion and generates $33.94 million in revenue each year. The consumer goods maker earns $-18,330,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

How many employees does Cryoport have?

Cryoport employs 105 workers across the globe.

What is Cryoport's official website?

The official website for Cryoport is www.cryoport.com.

Where are Cryoport's headquarters?

Cryoport is headquartered at 112 Westwood Place Suite 350, Brentwood TN, 37027.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]

This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.